D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
AVBP holding history
ArriVent BioPharma, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVBP overviewAll 13F holders of AVBPFull Q2 2026 holdings
- Shares (Q2 2026)
- 872,011
- Value
- $30.3M
- % of portfolio
- <0.1%
- Quarters held
- 4
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 872,011 | $30.3M | <0.1% | +503,216+136.4% | Added | Holders |
| Q1 2026 | 368,795 | $8.51M | <0.1% | +135,471+58.1% | Added | Holders |
| Q4 2025 | 233,324 | $4.69M | <0.1% | +233,324 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −8,775−100.0% | Sold out | Holders |
| Q3 2024 | 8,775 | $206.2K | <0.1% | +8,775 | New | Holders |